Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2013

01-08-2013 | Erratum

Erratum to: Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway

Authors: Fangyuan Wei, Douglas C Moore, Lei Wei, Yanlin Li, Ge Zhang, Xiaochun Wei, Joseph K Lee, Qian Chen

Published in: Arthritis Research & Therapy | Issue 4/2013

Login to get access

Excerpt

After publication of our recent article [1], we noticed that this study was initiated in Qian Chen's lab and that we had inadvertently omitted Qian Chen as a co-author. The study was also supported by other grants from NIH. Revised acknowledgment and authors' contribution paragraphs appear below. …
Literature
1.
go back to reference Wei F, Moore DC, Li Y, Zhang G, Wei X, Lee JK, Wei L: Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther. 2012, 14: R177-10.1186/ar3930.PubMedCentralCrossRefPubMed Wei F, Moore DC, Li Y, Zhang G, Wei X, Lee JK, Wei L: Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway. Arthritis Res Ther. 2012, 14: R177-10.1186/ar3930.PubMedCentralCrossRefPubMed
Metadata
Title
Erratum to: Attenuation of osteoarthritis via blockade of the SDF-1/CXCR4 signaling pathway
Authors
Fangyuan Wei
Douglas C Moore
Lei Wei
Yanlin Li
Ge Zhang
Xiaochun Wei
Joseph K Lee
Qian Chen
Publication date
01-08-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4242

Other articles of this Issue 4/2013

Arthritis Research & Therapy 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.